Nepal Opens Investigation into Record-Breaking Everest Climb Using Xenon Gas
- Four British Army veterans summited Mount Everest in under five days on May 21, 2025, after flying from London on May 16 and arriving at base camp on May 17.
- The team used xenon gas treatment administered in Germany before departure, aiming to reduce altitude sickness without the typical weeks-long acclimatisation, prompting debate over its safety and ethics.
- The expedition, organized by Furtenbach Adventures, employed around 120 local workers paid competitively and included training in hypoxic tents and other acceleration methods.
- The UIAA stated xenon offers no proven benefit for altitude climbs and warned side effects like impaired brain and respiratory function could be fatal, while Nepal investigates the use amid ongoing safety concerns.
- Nepalese officials face a dilemma balancing safety, fairness, and economic impact as short-duration climbs challenge traditional Everest expeditions, with Furtenbach confident the investigation will clear the team.
41 Articles
41 Articles
From Home to the Top of Everest in Five Days: the Express Marketing of the Highest Mountain Is Born
From London to the top of Everest in five days. Or, what is similar, opening a new way to stand on top of the planet reserved for the rich or, at least, for people with enormous economic possibilities. The English Garth Miller, Alistair Carns, Anthony Stazicker and Kevin Goodlington, all ex-military, took off on May 16 to Kathmandu and reached the peak of 8,848 meters this Wednesday after disbursing 150,000 euros per head. The challenge was to l…
British soldiers use xenon gas to scale Everest. What is it controversial?
Four former British special forces soldiers – Garth Miller, Alistair Carns, Anthony Stazicker, and Kev Godlington – used xenon gas to aid in their climb of Mount Everest in under five days. While some say inhaling the colourless, odourless gas reduces altitude sickness and aids in the production of red blood cells, experts and authorities remain unconvinced
Coverage Details
Bias Distribution
- 45% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage